State Of Alaska, Department Of Revenue Arcus Biosciences, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $8.91 Billion
- Q2 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 32,041 shares of RCUS stock, worth $533,803. This represents 0.01% of its overall portfolio holdings.
Number of Shares
32,041
Previous 32,931
2.7%
Holding current value
$533,803
Previous $621,000
21.58%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding RCUS
# of Institutions
207Shares Held
48.9MCall Options Held
173KPut Options Held
151K-
Black Rock Inc. New York, NY9.76MShares$163 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.26MShares$87.6 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA4.25MShares$70.7 Million0.65% of portfolio
-
State Street Corp Boston, MA3.06MShares$50.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.83MShares$30.6 Million0.08% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.2B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...